PPG
37
4
DAL
40
4
OI
33
7
TDC
28
2
HSY
34
3
VZ
47
3
MSFT
53
3
SNA
50
7
IFF
39
6
DOV
56
6
HSIC
47
3
IP
47
5
EBAY
38
4
VTR
49
6
GPC
50
6
KIM
63
5
NSC
48
14
FSLR
46
14
EQT
37
6
TXN
35
6
PPG
37
4
DAL
40
4
OI
33
7
TDC
28
2
HSY
34
3
VZ
47
3
MSFT
53
3
SNA
50
7
IFF
39
6
DOV
56
6
HSIC
47
3
IP
47
5
EBAY
38
4
VTR
49
6
GPC
50
6
KIM
63
5
NSC
48
14
FSLR
46
14
EQT
37
6
TXN
35
6
Financhill
Back

Genmab AS Stock Predictions

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

GMAB
Genmab AS

Last Price:
$18.82
Seasonality Move:
11.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Shocking Video Could Open Weekend Income Doors.

Go Here Now to Watch it

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 25.4% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $18.81. The Score for GMAB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 25.4% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Sell
45
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
30.41
52-Week Low:
17.24

Prediction Charts

Market Cap:
12B
Price in USD:
18.81
Volume:
1.5M
Beta:
0.71

Technical Analysis

SMA50:
20.43
SMA100:
20.72
SMA200:
23.11
52-Wk Change:
-36.75%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 18.81 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 19.67 19.06 19.68 19.00
Mar-26 19.73 19.62 19.83 19.52
Mar-27 19.94 20.14 20.37 19.94
Mar-28 19.81 19.90 19.96 19.73
Mar-31 19.53 19.58 19.66 19.36
Apr-1 19.09 18.66 19.10 18.62
Apr-2 18.48 18.82 18.85 18.48
Apr-3 19.19 19.24 19.32 19.00
Apr-4 18.80 18.39 18.89 18.30
Apr-7 18.02 18.19 18.68 17.82
Apr-8 18.89 17.98 18.92 17.77
Apr-9 17.69 18.83 18.97 17.24
Apr-10 18.68 18.01 18.70 17.58
Apr-11 18.64 18.81 18.88 18.44

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $5.15 per share, an increase this year of $0.17 per share, and an increase next year of $0.31 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.